Shrine

30 timestamped statements across 1 topic — auto-found in recorded discussions, each timestamp jumps to the exact moment. Summaries Shrine gave as host are listed separately below.

Featured statements

▶ Ep 64 · 9:00
testicular tissue cryopreservation relies on the future development of technologies in order to allow for the maturation of spermatogonial stem cells into mature sperm that can be used for fertilization and eventual pregnancy
▶ Ep 64 · 9:00
fertility preservation before puberty is much more of a challenging issue to address, particularly in males where you have a limited ability to do or no ability to do sperm cryopreservation

Nothing matches these filters — clear the search or widen the filters.

Shrine's statements about Pediatric Oncology 30 statements

Open the Pediatric Oncology collection →

Options for Male Fertility Preservation: Pediatric Oncofertility 2017

▶ Ep 64 · 0:08
clinical The testes has a greater chemo and radio sensitivity than the ovaries. ↗
▶ Ep 64 · 0:08
clinical Chemotherapeutic agents used for pediatric cancer treatment readily cross the blood testes barrier and primarily affect cells undergoing spermatogenesis due to their high mitotic rate. ↗
▶ Ep 64 · 0:08
clinical Leydig cells that produce testosterone are less sensitive to chemotherapy but can have sensitivity to radiation at very high doses. ↗
▶ Ep 64 · 0:08
clinical Males have no protective effect of receiving treatment at a younger age, which differs from females. ↗
▶ Ep 64 · 0:08
clinical Retroperitoneal lymph node dissections for testicular cancer can damage sympathetic nerves that control antegrade ejaculation, leading to fertility issues. ↗
▶ Ep 64 · 0:08
quote males have no protective effect of receiving treatment and having exposure at a younger age, which doesn't seem to be the case in females ↗
▶ Ep 64 · 0:08
quote the testes has a greater chemo and radio sensitivity than the ovaries ↗
▶ Ep 64 · 3:00
quote the quality of semen analysis and DNA integrity can be compromised after even a single course of treatment ↗
▶ Ep 64 · 3:00
quote we really don't recommend age to be considered in isolation when deciding whether to offer sperm cryopreservation to a patient ↗
▶ Ep 64 · 3:00
quote stage of puberty development is a better, um, indicator to mark you than age ↗
▶ Ep 64 · 3:00
quote sperm cryopreservation is the most established option for fertility preservation ↗
▶ Ep 64 · 3:00
clinical Electroejaculation with insertion of a probe into the rectum can harvest a specimen and needs to be performed under general anesthesia. ↗
▶ Ep 64 · 3:00
clinical Sperm cryopreservation should be offered prior to treatment, as the quality of semen analysis and DNA integrity can be compromised after even a single course of treatment. ↗
▶ Ep 64 · 3:00
opinion Stage of puberty development (typically Tanner stage 3 or above) is a better indicator than age for determining when to offer sperm cryopreservation. ↗
▶ Ep 64 · 6:20
clinical Testicular sperm extraction (TESE) involves retrieval of sperm from focal areas of spermatogenesis in the seminiferous tubules for later use with ICSI. ↗
▶ Ep 64 · 7:26
quote they were only able to actually find successful, um, sperm that they could use later for ICSI in those percentages. So, um, it's almost a fifty-fifty chance on average on whether it's successful, but these are patients that really have no other option because they're zoospermic when they're providing a semen specimen ↗
▶ Ep 64 · 7:45
clinical Microscopic assistance in TESE allows better identification of tubules that potentially contain sperm and has improved retrieval rates in adult literature. ↗
▶ Ep 64 · 8:01
quote it has in the adult literature. There's really nothing in terms of the pediatric literature in terms of improving sperm retrieval rate, but it has in the adults ↗
▶ Ep 64 · 9:00
quote testicular tissue cryopreservation relies on the future development of technologies in order to allow for the maturation of spermatogonial stem cells into mature sperm that can be used for fertilization and eventual pregnancy ↗
▶ Ep 64 · 9:00
quote No successful retrieval of mature sperm or pregnancies have been reported to date ↗
▶ Ep 64 · 9:00
clinical Fertility preservation before puberty in males is challenging due to the absence of mature sperm that can be cryopreserved. ↗
▶ Ep 64 · 9:00
clinical Preserving fertility in prepubertal males is contingent on future development of experimental therapies for maturation of spermatogonial stem cells to sperm. ↗
▶ Ep 64 · 9:00
clinical Spermatogonial stem cell therapies developed in animal models include direct transplantation into the testicle, transplantation of testicular tissue as autologous or xenograft, and in vitro sperm maturation, but none have been performed successfully in humans. ↗
▶ Ep 64 · 9:00
clinical Testicular tissue cryopreservation involves harvesting immature testicular tissue prior to treatment initiation and cryopreservation with slow freezing techniques. ↗
▶ Ep 64 · 9:00
clinical At Cincinnati Children's, testicular tissue cryopreservation eligibility includes pediatric males 6 months to 17 years with >80% risk of long-term azoospermia, and adults 18-25 years with 21-79% risk. ↗
▶ Ep 64 · 9:00
clinical The excisional biopsy is coordinated with other surgical procedures to minimize anesthetic risk and expedite treatment initiation, performed through a transscrotal approach. ↗
▶ Ep 64 · 9:00
clinical 75% of harvested testicular tissue is stored at Reprotech for patient use and 25% is designated for research at McGee Women's Research Institute. ↗
▶ Ep 64 · 9:00
clinical No successful retrieval of mature sperm or pregnancies from cryopreserved testicular tissue have been reported to date in humans. ↗
▶ Ep 64 · 9:00
quote fertility preservation before puberty is much more of a challenging issue to address, particularly in males where you have a limited ability to do or no ability to do sperm cryopreservation ↗
▶ Ep 64 · 9:00
quote none of these technologies have actually been performed successfully in humans at this point ↗

Summaries Shrine gave as host · 14 summaries

Recaps of what the experts said, with Shrine as narrator — not Shrine's own clinical position, and never cited in answers.

Summaries Shrine gave as host · Pediatric Oncology 14 summaries

Open the Pediatric Oncology collection →

Options for Male Fertility Preservation: Pediatric Oncofertility 2017

▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: azoospermia, which is the absence of sperm, was present in only 16.9% of untreated patients versus 84% of patients who were treated and then subsequently tried to perform sperm cryopreservation ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: in the youngest age group between 11 to 14 years of age 65% of the patients were able to successfully sperm bank, which is a fairly high percentage ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: In the Philadelphia study, semen volume, total motile count, and rate of azoospermia improved with increasing age on both univariate and multivariate analysis. ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: In the youngest age group (11-14 years), 65% of patients were able to successfully sperm bank. ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: The mean and median semen volume, concentration, and motility in the adolescent cohort were greater than WHO criteria derived from fertile adult males. ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: The American Society of Clinical Oncology recommends that sperm cryopreservation should be offered to all peri and postpubertal adolescents who are able to provide a semen specimen. ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: In a Philadelphia cohort, azoospermia was present in only 16.9% of untreated patients versus 84% of patients who were treated and then subsequently tried to perform sperm cryopreservation. ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: Several centers have demonstrated successful sperm banking in greater than 80% of patients, with a median of 1.5 attempts and 7 samples per patient. ↗
▶ Ep 64 · 3:00
host summary Shrine summarizing the discussion: Studies have shown that adequate semen specimens can be obtained in adolescents as young as 11 years of age. ↗
▶ Ep 64 · 6:20
host summary Shrine summarizing the discussion: Sperm was successfully extracted from an adolescent as young as 11 years of age, but not from any child below Tanner stage 3 development. ↗
▶ Ep 64 · 6:20
host summary Shrine summarizing the discussion: Successful sperm retrieval with TESE has been reported in 47% of patients prior to chemotherapy and 37-65% after chemotherapy. ↗
▶ Ep 64 · 6:20
host summary Shrine summarizing the discussion: In a study subset of adolescents and young adults aged 11-19 years, 33% sperm retrieval rate was reported prior to treatment. ↗
▶ Ep 64 · 6:20
host summary Shrine summarizing the discussion: they weren't able to do it in any child that was below 10 or stage 3 development ↗
▶ Ep 64 · 9:00
host summary Shrine summarizing the discussion: Studies have demonstrated high satisfaction and acceptance of risk for testicular tissue cryopreservation among patients and families. ↗